Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T16:16:52.776Z.
Calculation as of: 2026-10-06T16:16:52.776Z.
Quote observation: 2026-10-06T16:10:38.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fe223a2c9097866a428bc5ebda2476775355ce68fd4daeb413d6e89482dd9b46
PEG RATIO
N/A
GlucoTrack, Inc.
Market Cap
$869976.00
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| GlucoTrack, Inc. (GCTK) | $869976.00 | N/A |
| Bone Biologics Corporation (BBLG)vs › | $859931.00 | N/A |
| Sunshine Biopharma, Inc. (SBFM)vs › | $869274.00 | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $845829.00 | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $820321.00 | N/A |
| Ridgetech, Inc. (RDGT)vs › | $809925.00 | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | N/A |
| CDT Equity Inc. (CDT)vs › | $662826.00 | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
